可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Askarl AT, Unzek S, Popovic ZB, et al. Effect of stromal-cellderived factor -1 on stem-cell homing and tissue regeneration in ischemic cardiomyopathy[J]. Lancet, 2003, 362(9385):697-703.
[2] Chen X, Ren S, Ma MG, et al. Hirulog-like peptide reduces restensis and expression of tissue factor and transforming growth factor-beta in carotid artery of atherosclerotic rabbits[J]. Atherosclerosis, 2003, 169(1):31-40.
[3] Gensini GG. A more meaningful scoring system fordeterming the severity of coronary heart disease[J]. Am J Cardiol, 1983, 51(3):606.
[4] Sukhija R, Fahdi I, Garza L, et al. Inflammatory marker,angiographic severity of coronary artery disease, and patient outcome[J]. Am J Cardiol, 2007, 99(7):879-884.
[5] Li JJ, Nie SP, Xu B, et al. Inflammation in variant angina: is there any evidene?[J]. Med Hypotheses, 2007, 68(3):635-640.
[6] Dams JK, Waehre T, Yndestad A, et al. Stromal cell-derived facto-1 in unstable an-gina potential and inflammatory and matrix-stabilizing effects[J]. Circulation, 2002, 106(1):36-32.
[7] Abi-Younes S, Sauty A, Mach F, et al. The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques[J]. Circ Res, 2000, 86(2):131-138.
[8] Poznasky MC, Olszsk IT, Foxall R, et al. Active movement of T cell away from a chemokine[J]. Nat Med, 2000, 6(5):543-548.
[9] De Falco E, Porcelli D, Torella AR, et al. SDF-1 involvement in endothelial pheno type and ischemia-induced recruitment of bone marrow progenitor cells[J]. Blood, 2004, 104(12): 3472-3482.
[10]Ma J, Ge J, Zhang S, et al. Time course of myocardial stro-mal cell-derived factor 1 expression and beneficial effects of intravenously administered bone marrow stem cells in rats with experimental myocardial infarction[J]. Basic Res Cardio1, 2005, 100(3):217-223.